Merck Ltd. and the government-funded Development Center for Biotechnology (DCB) jointly announced yesterday a cooperation agreement to establish an Asia Technology Training Center (ATTC) in Taiwan.
Merck will invest approximately NT$10 million (US$308,000) in the training center, bringing its own systems and plans to have two to three lab technicians in addition to a technical manager, who will be responsible for coordinating clients throughout Asia, said William Chen (
"The initial investment is small, but the potential return on capital is exponential," he said.
Since DCB will be providing a majority of the talent and support, Merck will have a smaller staff, Chen said.
"The key is our technical manager, who will have to act as coordinator for clients across Asia and rely on our expertise in scale production of protein-based drugs and consulting services," Chen said.
"The ATTC is not merely a training center; it is where clients can come and use our expertise and perhaps inquire about technology transfer," he said.
German-based Merck established its Taiwan branch in 1989 and distributes laboratory equipment and raw ingredients for research in sciences. The company has two training centers in the world -- one in Germany and another in the US. ATTC will be the third facility and the only one in Asia.
Under the agreement, Merck will set up ATTC on the DCB campus in Sijhih City (汐止), Taipei County. DCB will provide the space, facilities, consultants and supplies, while Merck will share its cooperation model with customers and partner DCB in its global R&D efforts.
The competition to house this facility was high, with Japan, China, India and South Korea all vying for the opportunity to enhance their biotechnology sector, DCB officials said.
"DCB is quite pleased to have won Merck's approval. The joint proposal drawn up by Merck Taiwan and DCB was done within a week and beat out proposals from other Asian countries -- some of which had been working on the proposals for a year," said Huang Bor-fuei (
DCB and Merck Taiwan were able to edge out the competition as their proposal went beyond the simple concept of a "training center" and incorporated more business integration opportunities, Huang said.
Taiwan has an advantage in this sector in Asia because of its clear rules on intellectual property rights protection, DCB's well-established bioprocessing team and R&D facilities, and a current good manufacturing practice, or CGMP, pilot plant to support large-scale production, he said.
DCB chairman Wu Shuh-min (
Wu was referring to the legislature's approval of the Biotech and New Pharmaceutical Development Act (
"It also shows that Merck recognizes the efforts DCB has made in 2007 on the international stage, striking cooperation deals with Boehringer Ingelheim of Germany, Crucell of Netherlands and MediVas of the United States," Wu said
Looking ahead, DCB, and by corollary, Taiwan's biotechnology industry, will benefit from more international exposure and recognition, and smaller biotech firms will gain access to world-class consulting and services in protein-based drug production, Huang said.
One of several Taiwanese biotechnology firms present at yesterday's event said it had learned more about potential opportunities to cooperate with DCB.
“The case put forward by DCB looks good, and if costs are acceptable we will probably seek to cooperate with them. The services that Merck and DCB provide certainly helps the process of protein-based drug production,” said
Cheng Li-ting (鄭力廷), a researcher at Sijhih-based Yeastern Biotech Co Ltd (益生生技).
SUPPORT: The government said it would help firms deal with supply disruptions, after Trump signed orders imposing tariffs of 25 percent on imports from Canada and Mexico The government pledged to help companies with operations in Mexico, such as iPhone assembler Hon Hai Precision Industry Co (鴻海精密), also known as Foxconn Technology Group (富士康科技集團), shift production lines and investment if needed to deal with higher US tariffs. The Ministry of Economic Affairs yesterday announced measures to help local firms cope with the US tariff increases on Canada, Mexico, China and other potential areas. The ministry said that it would establish an investment and trade service center in the US to help Taiwanese firms assess the investment environment in different US states, plan supply chain relocation strategies and
Hon Hai Precision Industry Co (鴻海精密) is reportedly making another pass at Nissan Motor Co, as the Japanese automaker's tie-up with Honda Motor Co falls apart. Nissan shares rose as much as 6 percent after Taiwan’s Central News Agency reported that Hon Hai chairman Young Liu (劉揚偉) instructed former Nissan executive Jun Seki to connect with French carmaker Renault SA, which holds about 36 percent of Nissan’s stock. Hon Hai, the Taiwanese iPhone-maker also known as Foxconn Technology Group (富士康科技集團), was exploring an investment or buyout of Nissan last year, but backed off in December after the Japanese carmaker penned a deal
WASHINGTON POLICY: Tariffs of 10 percent or more and other new costs are tipped to hit shipments of small parcels, cutting export growth by 1.3 percentage points The decision by US President Donald Trump to ban Chinese companies from using a US tariff loophole would hit tens of billions of dollars of trade and reduce China’s economic growth this year, according to new estimates by economists at Nomura Holdings Inc. According to Nomura’s estimates, last year companies such as Shein (希音) and PDD Holdings Inc’s (拼多多控股) Temu shipped US$46 billion of small parcels to the US to take advantage of the rule that allows items with a declared value under US$800 to enter the US tariff-free. Tariffs of 10 percent or more and other new costs would slash such
SENSOR BUSINESS: The Taiwanese company said that a public tender offer would begin on May 7 through its wholly owned subsidiary Yageo Electronics Japan Yageo Corp (國巨), one of the world’s top three suppliers of passive components, yesterday said it is to launch a tender offer to fully acquire Japan’s Shibaura Electronics Co for up to ¥65.57 billion (US$429.37 million), with an aim to expand its sensor business. The tender offer would be a crucial step for the company to expand its sensor business, Yageo said. Shibaura Electronics is the world’s largest supplier of thermistors, with a market share of 13 percent, research conducted in 2022 by the Japanese firm showed. If a deal goes ahead, it would be the second acquisition of a sensor business since